1,385
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Lasting Gammaproteobacteria profile changes characterized hematological cancer patients who developed oral mucositis following conditioning therapy

, , , ORCID Icon, , , & show all
Article: 1761135 | Received 19 Nov 2019, Accepted 13 Apr 2020, Published online: 13 May 2020

References

  • Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15(12):1628–10.
  • D’Souza A, Fretham C Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides. 2018. [cited 2019 Oct 29]. https://www.cibmtr.org.
  • Peterson DE, Srivastava R, Lalla RV. Oral mucosal injury in oncology patients: perspectives on maturation of a field. Oral Dis. 2015;21(2):133–141.
  • Sonis ST. New thoughts on the initiation of mucositis. Oral Dis. 2010;16(7):597–600.
  • Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008;52(1):61–77, viii.
  • Elting LS, Cooksley CD, Chambers MS, et al. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68(4):1110–1120..
  • Elting LS, Keefe DM, Sonis ST, et al. Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer. 2008;113(10):2704–2713..
  • Nonzee NJ, Dandade NA, Patel U, et al. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis: results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008;113(6):1446–1452
  • Elting LS, Chang YC. Costs of oral complications of cancer therapies: estimates and a blueprint for future study. J Natl Cancer Inst Monogr. 2019;2019:53.
  • Brennan MT, Hasseus B, Hovan AJ, et al. Impact of oral side effects from conditioning therapy before hematopoietic stem cell transplantation: protocol for a multicenter study. JMIR Res Protoc. 2018;7(4):e103.
  • Saunders DP, Epstein JB, Elad S, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3191–3207.
  • Vasconcelos RM, Sanfilippo N, Paster BJ, et al. Host-microbiome cross-talk in oral mucositis. J Dent Res. 2016;95(7):725–733.
  • Ye Y, Carlsson G, Agholme MB, et al. Pretherapeutic plasma pro- and anti- inflammatory mediators are related to high risk of oral mucositis in pediatric patients with acute leukemia: aprospective cohort study. PLoS One. 2013;8(5):e64918.
  • Hong BY, Sobue T, Choquette L, et al. Correction to: stochastic processes shape microeukaryotic community assembly in a subtropical river across wet and dry seasons. Microbiome. 2019;7(1):66..
  • Haverman TM, Raber-Durlacher JE, Rademacher WM, et al. Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediators Inflamm. 2014;2014;378281.
  • Laheij A, Raber-Durlacher JE, Koppelmans RGA, et al. Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients. Sci Rep. 2019;9(1):16929.
  • Mougeot JC, Stevens CB, Morton DS, et al. Oral microbiome and cancer therapy-induced oral mucositis. J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53). pii: lgz002. doi: 10.1093/jncimonographs/lgz002.
  • Gomes BP, Berber VB, Kokaras AS, et al. Microbiomes of endodontic-periodontal lesions before and after chemomechanical preparation. J Endod. 2015;41(12):1975–1984
  • Mougeot JL, Stevens CB, Cotton SL, et al. Concordance of HOMIM and HOMI NGS technologies in the microbiome analysis of clinical samples. J Oral Microbiol. 2016;8(1):30379.
  • Mougeot JC, Stevens CB, Almon KG, et al. Caries-associated oral microbiome in head and neck cancer radiation patients: A longitudinal study. J Oral Microbiol. 2019;11(1):1586421. doi:10.1080/20002297.2019.1586421
  • Caporaso JG, Lauber CL, Walters WA, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4516–4522..
  • Afgan E, Baker D, Batut B, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018;46(W1):W537–W544.
  • Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.
  • Kaul A, Mandal S, Davidov O, et al. Analysis of microbiome data in the presence of excess zeros. Front Microbiol. 2017;8:2114.
  • Core Team R. A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017. [accessed 2019 Oct 29]. http://www.R-project.org/.
  • Sergeant ESG Epitools epidemiological calculators. Ausvet Pty Ltd; [cited 2019 Oct 29]. http://epitools.ausvet.com.au.
  • Villa A, Sonis ST. Mucositis: pathobiology and management. Curr Opin Oncol. 2015;27(3):159–164.
  • Krishnan K, Chen T, Paster BJ. A practical guide to the oral microbiome and its relation to health and disease. Oral Dis. 2017;23(3):276–286.
  • Furquim CP, Soares GM, Ribeiro LL, et al. The salivary microbiome and oral cancer risk: a pilot study in fanconi anemia. J Dent Res. 2017;96(3):292–299
  • Kosikowska U, Rybojad P, Stepien-Pysniak D, et al. Understanding pneumococcal serotype 1 biology through population genomic analysis. BMC Infect Dis. 2016;16(1):449..
  • Wang K, Lu W, Tu Q, et al. Preliminary analysis of salivary microbiome and their potential roles in oral lichen planus. Sci Rep. 2016;6(1):22943.